Brian I. Rini, MD
Co-Leader, GU Malignancies Programrinib2@ccf.org 216.444.9567 (o) 216.444.9464 (f)
Professor, Hematology and Oncology
At Cleveland Clinic, Dr. Rini's primary research has been in renal cell carcinoma (RCC) and prostate cancer, with a special focus on antiangiogenic therapy and immunotherapy. Dr. Rini's research has been published in peer-reviewed journals that include Journal of the National Cancer Institute, Journal of Clinical Oncology, Cancer, Lancet and JAMA. He is a member of the editorial boards of Journal of Clinical Oncology, Cancer and British Journal of Urology.